- Home
- AVIR vs PRE Comparison
AVIR vs PRE Comparison
Compare AVIR & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | PRE |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.9M | 369.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | PRE |
|---|---|---|
| Price | $5.76 | $19.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.00 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 577.0K | 182.9K |
| Earning Date | 05-11-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | $105.52 |
| Revenue Next Year | N/A | $58.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $3.09 |
| 52 Week High | $6.45 | $23.63 |
Technical Indicators
Market Signals| Indicator | AVIR | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 59.48 | 49.41 |
| Support Level | $3.33 | $12.35 |
| Resistance Level | $6.45 | $23.06 |
| Average True Range (ATR) | 0.28 | 1.69 |
| MACD | -0.07 | -0.23 |
| Stochastic Oscillator | 63.36 | 21.00 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.